2Jeremias I,Herr I,Boehler T,Debatin KM.TRAIL/Apo-2-ligand-induced apoptosis in humsn T cells[J].Eur JImmunol 1998; 28(1):143-152.
3Pan G,O'Rourke K,Chinnaiyan AM,Gentz R,Ebner R,Ni J,et al.The receptor for the cytotoxic ligand TRAIL[ J].Science 1997;276(5309):111-113.
4Song CJ,Liu XS,Zhu Y,Chen LH,Jia W,Li YN,et al.Expression of TRAIL,DR4,and DR5 in kidney and serum from patients receiving renal transplantation[J].Transplant Proc 2004;36(5):1340-1343.
5Xie L,Shi W,Guo P.Roles of tumor necrosis factor-related apoptosis-inducing ligand in corneal transplantation [J].Transplantation 2003;76(11):1556-1559.
6Song K,Chen Y,Goke R,Wilmen A,Seidel C,Goke A,et al.Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression[ J].Exp Med 2000; 191 (7):1095-1104.
7Wiley SR,Schooley K,Smolak PJ,Din WS,Huang CP,Nicholl JK,et al.Identification and characterization of a new member of the TNF family that induces apoptosis [J].Immunity 1995;3(6) :673-682.
8Pitti RM,Marsters SA,Ruppert S,Donahue CJ,Moore A,Ashkenazi A,et al.Induction of apoptoois by Apo2 ligand,a new member of the tumor nectosis factor cytokine family[J].J Bio1 Chem 1996;271(22):12687-12690.
9Williams KA,Coster DJ.Penetrating corneal transplantation in theinbred rat:a new model[ J].Invest Ophthalmol Vis Sci 1985;26(1):23-30.
10Holland EJ,Chan CC,Wetzig RP,Palestine AG,Nussenblatt RB.Clinical and immunohistoogic studies of corneal rejection in the rat penetrating keratoplasty model [ J ].Cornea 1991; 10(5) :374-380.
